or MIM+2,3-DHP (100 mg of MIM plus 100 mg of 2,3-DHP-kg.75.d-1) on hepatic function and selected blood metabolite and circulating hormone concentrations. Neither MIM nor 2,3-DHP affected plasma ammonia N, glucose, cortisol, or insulin concentrations over time ( P > .lo). Jugular plasma total protein concentration was greater in the MIM group ( P < .07). Plasma triiodothyronine ( P < .01) and thyroxine ( P < .08) concentrations were higher in the goats receiving the MIM, 2,3-DHP7 and MIM+2,3-DHP infusions than in the goats receiving the CON infusion. Plasma urea N concentration was decreased by MIM ( P < . l o ) and MIM+2,3-DHP ( P < .03) compared with the CON infusion. A Propionate Load Test was conducted at 24 to 28 h into the infusion to assess the toxins' effects on the liver's ability to increase circulating glucose concentrations in the presence of elevated propionate levels. The results indicated that neither 2,3-DHP nor MIM reduced the liver's ability to respond to a bolus dose of propionate ( P > .lo). Following a Urea Load Test, circulating ammonia N and glucose concentrations in the MIM, 2,3-DHP7 and MIM+2,3-DHP treatments had lower peak values than that in the CON treatment ( P < .01). It is concluded that continuous short-term infusion of MIM and 2,3-DHP increased circulating thyroid hormone concentrations in goats and improved the goats' ability to detoxify a bolus dose of urea N without affecting its glucogenic capacity in response t o elevated propionate levels.
Introduction
Leucaena leucocephala is a tropical leguminous shrub or tree with 22 to 34% CP (Jones, 1979) and is considered t o be a promising source of protein for ruminants in the tropics (Benge, 1980 J. Anim. Sci. 1994. 72:415-420 however, is limited by the presence of the toxic alkaloid, mimosine, an amino acid-like compound, and its ruminal fermentation product, dihydroxypyridine (both 2-hydroxy-3[1Hl-pyridone and 3-hydroxy-4[lH]-pyridone; Hegarty et al., 1979; El-Harith et al., 1987) . These substances have been shown to reduce feed intake, and cause alopecia, goiter, renal and liver dysfunction, and general inefficiency in various domestic species, and, in extreme cases, death (Jones, 1979; Jones and Hegarty, 1984) . In addition, mimosine has been reported to influence various serum enzyme activities and to possibly interfere with the metabolism of some amino acids, notably glycine (ElHarith et al., 1981) . Furthermore, 3,4-dihydroxypyridine was classified as a thiouracil-type goitrogen with a general peroxidase inhibiting action Hegarty et al., 1979) .
Although various signs of toxicity and several serum enzyme activities have been reported, the effects of mimosine and 2,3 or 3,4-dihydroxypyridine on metabolic processes involved in the partitioning of nutrients have received limited attention. The objectives of this study were to determine the effects of elevated blood levels of these Leucaena toxins on selected blood metabolite and hormone concentrations involved in nutrient partitioning and to assess the toxins' effects on hepatic function as determined by the goats' response to propionate and urea load tests.
Materials and Methods
Sixteen, growing, Alpine wethers ( 8 mo of age, average BW 35 f 2 kg) were blocked by weight and randomly assigned to one of four treatment groups: 1) physiological saline ( CON) ; 2 ) mimosine ( MIM; 200 mg-kg BW.75&1) ; 3) 2,3-dihydroxypyridine ( 2,3-DHP; 200 mg-kg BW.75&1), or 4 ) MIM (100 mg-kg BW.75.d-1) plus 2,3-DHP (100 mgkg BW.75.d-1) ( MIM+2,3-DHP). In the present trial, 2,3-DHP was used as a model for the major ruminal fermentation product of mimosine, 3,4-DHP, due to its commercial availability. Both 3,4-DHP and its isomer, 2,3-DHP are produced by degradation of mimosine following ingestion and mastication of Leucaena by ruminants (Jones, 1985) . The dosage level and length of treatment used in this experiment was based on previous studies conducted with sheep (Reis, 1975 (Reis, , 1978 Reis et al., 1975) and Angora goats (Jacquemet et al., 1990) , which resulted in defleecing of the treated animals. Moreover, these infusion levels reflect a 40% Leucaena diet containing 2% mimosine for a 60-kg goat a t an intake of 3% of BW. The wethers were placed in individual metabolism cages and given ad libitum access to a completely mixed diet (Table 1 ) along with fresh water. Goats were offered fresh feed daily at 0830, although feed was withheld during the infusion period because Jacquemet et al. (1990) observed a confounding effect between feed intake and the infusion of mimosine. Goats were fitted with indwelling right (infusion) and left (withdrawal) jugular vein catheters 1 d before the start of the infusion. Mimosine from Leucaena seed was 99% pure (Sigma Chemical, St. Louis, MO), and 2,3-DHP was 98% pure (Aldrich Chemical, Milwaukee, WI). The respective treatments were dissolved in physiological saline and the pH adjusted to 7.4, and the solutions were infused continuously at a rate of 10 mL/h for 48 h using portable peristaltic infusion pumps (Siropump, Everest Electronics, Seaford, Australia).
Blood samples were collected from each goat into two 7-mL vacuum tubes containing K3EDTA and potassium oxalate with sodium fluoride (Becton Dickinson Vacutainer System, Rutherford, N J ) a t 0,6, 12, 18, and 24 h after dosing. Immediately after sampling, the blood was chilled in an ice bath and centrifuged at 1,500 x g at 4°C for 20 min. Plasma samples were stored at -20°C until they were further analyzed.
A Propionate Load Test was conducted between 24
to 28 h after dosing according to the method of Grohn et al. (1985) using a sodium propionate saline solution of 3 mmolkg BW in a pulse dose. Blood samples were taken a t 0, 5 , 10, 15, 20, 30, and 40 min after dosing and analyzed for glucose.
A Urea Load Test was conducted between 36 to 42 h after dosing according to the methods of Fernandez et al. (1990a) using a urea solution of .3 g/kg BW via stomach tube. Blood samples for the Urea Load Test were taken at 0, 15, 60, 120, 180, 240, 360, and 480 min after dosing and analyzed for plasma ammonia N, urea N, glucose, and insulin.
Plasma ammonia N and urea N were determined as described by Sahlu et al. (1992) . Plasma total protein (Sigma Kit #541) and glucose (Sigma Kit #315) were determined using commercial spectrophotometric methods. Plasma cortisol (ICN Kit #07-2211021, insulin (ICN Kit #07-160102), thyroxine (ICN Kit #07-290102), and triiodothyronine (ICN Kit #07-292102) were assayed using commercially available radioimmunoassay kits (ICN Biomedicals, Costa Mesa, CAI. All plasma hormone samples were assayed in duplicate in a single RIA run. The assays used hormone calibrators in human serum; the known sensitivities of the cortisol, insulin, thyroxine, and triiodothyronine RIA were .15 pgIdL, 1.4 pUlmL, .5 pgl dL, and 18 ngldL, respectively. Intraassay CV for same were 9.2, 7.3, 6.4, and 7.9%, respectively.
All variables were analyzed using the univariate repeated-measures analysis as a split-plot in time (Littel et al., 1991) with the GLM procedures (SAS, 1989), using 0-h values as covariates. Treatment and CAverage from analysis of four samples.
the treatment x time interaction were tested using appropriate error terms and when treatment effect was significant ( P < . l o ) , means were separated using the Tukey multiple-range test (Steel and Torrie, 1980) .
Results and Discussion
Plasma Metabolites and Hormones. There was no effect ( P > . l o ) of MIM, 2,3-DHP1 or MIM+2,3-DHP infusion on plasma ammonia N, glucose, cortisol, and insulin concentrations (Table 2 1. Sheep fasted from 24 to 72 h demonstrate a significant reduction in pancreatic insulin secretion and total splanchnic glucose output resulting in reduced peripheral blood concentrations of insulin and glucose (Heitmann et al., 1986) . In a previous study, plasma insulin concentrations, but not glucose levels, were reduced by MIM (Jacquemet et al., 1990) . Fernandez et al. (1991) reported no changes in plasma glucose, Llactate, or insulin concentrations as a result of daily intravenous bolus administration of MIM (60 mg.kg BW.75.d-1) over a 21-d period. These latter two studies (Jacquemet et al., 1990; Fernandez et al., 1991) were conducted in fed animals, whereas the present experiment was conducted in wethers deprived of feed for the duration of the infusion period.
Mimosine ( P < .lo) and the combination ( P < .03) decreased plasma urea N concentrations below those of the CON with means of 8.69, 7.52, and 9.95, respectively. Jacquemet et al. (1990) did not observe a change in plasma urea N, glucose, or nonesterified fatty acid concentrations in Angora goats receiving continuous intravenous MIM infusions over a 48-h period. However, Fernandez et al. (1991) reported elevated plasma urea N concentrations contrary to ours in MIM-treated lactating does. In addition, El-Harith et al. (1981) found an increase in serum urea N concentration when mimosine was fed to mice. The decrease in plasma urea N observed in this experiment may have been caused by the goats being deprived of feed during the infusion. The foregoing authors suggested that mimosine adversely affected kidney function. This is corroborated by Jacquemet et al. (19901, who reported uroschesis and edema in MIM-treated goats.
Infusion of MIM elevated ( P < .07) plasma total protein concentration above the saline control, 2,3-DHP, and the combination of the two Leucaena toxins (MIM+2,3-DHP) ( Table 2 ) . This agrees with previous reports in mimosine-treated goats (Jacquemet et al., 1990; Fernandez et al., 1991) .
Thyroxine concentrations were elevated ( P < .08) by the infusion of MIM, 2,3-DHP, and MIM+B,S-DHP (Table 2 ). This is contrary to previous reports by Christie et al. (1979) with mice, Quirk et al. (1988) with cattle, and Jacquemet et al. (1990) with Angora goats, but agrees with the findings of others (Jones and Megarrity, 1983; Jones and Hegarty, 1984; in studies using goats and steers. Mimosine, MIM+2,3-DHP1 and 2,3-DHP administration (in that order) increased ( P < .01) the plasma triiodothyronine concentration relative to the CON infusion. This was also observed by Jones and Hegarty (1984) at similar mimosine levels in cattle. In an experiment lasting 7 wk, Christie et al. (1979) observed an increased triiodothyronine concentration relative to the control when mice were fed diets containing 1% 3,4-DHP. Jones and Hegarty (1984) , however, argued that the triiodothyronine concentrations decreased with time and would have decreased to concentrations lower than the control if the experiment had lasted longer than 16 wk. In earlylactating does, plasma triiodothyronine concentration was 38% greater after 2 wk of MIM treatment, whereas no difference was noted in thyroxine concentrations (Fernandez et al., 1991) . The foregoing evidence suggests that triiodothyronine concentrations are indeed initially elevated by the presence of mimosine or 2,3-DHP in the blood; however, after several weeks triiodothyronine concentrations may start a gradual decline. Nevertheless, in the present study, the elevated triiodothyronine concentrations were unexpected because it has been reported that thyroxine concentrations were consistently lower and tended to decline after mimosine or 2,3-DHP infbsion or ingestion (Jones and Megarrity, 1983; Jones and Hegarty, 1984; .
The toxin, 3,4-DHP, has been classified as a thiouracil-type goitrogen that inhibits peroxidase activity, and hence, allowing iodide absorption by the thyroid gland but inhibiting its oxidation to iodine and its subsequent conversion to iodothyronines ). Limiting iodine availability may limit the formation of thyroxine relative to triiodothyronine. When thyroglobulin in the thyroid gland is totally depleted, then one would expect thyroxine and triiodothyronine concentrations in the blood to decline as suggested by Jones and Hegarty (1984) . In mice, 3,4-DHP affects the thyroid function by inhibiting iodine uptake by the thyroid gland at the iodinebinding step rather than the iodide-trapping step, and hence, 3,kDHP acts as a goitrogen in a similar manner as thiouracil. This effect can be observed in a matter of hours ( 3 to 5 h ) in pharmacologically treated mice (Hegarty et al., 1979) .
Propionate Load Test. According to Cornelius
(19891, the expected response by a normal sheep to a Propionate Load Test ( 3 mmoVkg BW; i.v.1 would be an increase in blood glucose of no less than 36 mg/dL ( o r 2 mmol/L) within 7 min after propionate administration. A smaller increase in glucose concentration would tend to suggest abnormal hepatic gluconeogenesis. Blood glucose concentrations of all treatments showed a greater than 2 mmoVL increase (40 to 57.8 mg/dL) within 5 min ( P < .001) after the administration of propionate; however, there were r 3 treatment x time interactions ( P < .12) and treatments did not differ (Table 3) . Therefore, it seems that the capacity of the liver to metabolize propionate to glucose was not altered by 2,3-DHP or MIM administration.
Urea Load Test. The Urea Load Test evaluates the ability of the liver to detoxify elevated concentrations of ammonia N as a result of increased ruminal degradation of urea N and accelerated ammonia N production (Fernandez et al., 1990b) . In the present experiment, goats receiving the CON infusion demonstrated the greatest increase in plasma ammonia N as a result of the Urea Load Test (Table 4 ). All t,reatments exhibited an increase in ammonia N with time ( P < .001), peaking a t 15 or 60 min after dosing. A treatment x time interaction ( P < .Ol) was also observed, with lower peak and subsequent concentrations of ammonia N in the MIM, 2,3-DHP, and MIM+2,3-DHP treatment groups than in the CON treatment group. Although the same urea dose ( .3 g of ureakg BW) was used, a higher peak response in jugular blood ammonia N (.87 mg/dL) was observed in a previous study (Fernandez et al., 1990b) . Bartley et al. (1981) suggested that ammonia N concentrations in the peripheral blood of steers exceeding .6 mg/ dL may be an indication that the liver's ability to detoxify ammonia may be compromised. In contrast, it has been proposed that upon absorption some of the ruminal ammonia may bypass splanchnic circulation, and consequently the liver, by being absorbed across the gastrointestinal tract directly into the lymphatic system, bypassing the portal circulation, resulting in increased peripheral blood ammonia N concentrations without ever having exceeded the liver's ability to detoxify the ammonia (Symonds et al., 1981; Fernandez et al., 1990a) . Plasma urea N peaked at a n average of 21.6 mg/dL at approximately 240 min after the Urea Load Test. In contrast, Fernandez et al. (1990b) reported peak urea N concentrations of 29.5 mg/dL at 480 min after urea drenching. The higher urea N concentrations found by Fernandez et al. (1990b) may have been due to the nonprotein nitrogen incorporated (urea consisting of 10% of total dietary N ) in the goats' diet. Glucose concentrations increased { P < .OOl) with time, as is characteristic with experimentally induced hyperammonemia (Bartley et al., 1981; Fernandez et al., 1990a) . Plasma glucose peaked at lower concentrations and remained at lower concentrations in the MIM, 2,3-DHP, and MIM+2,3-DHP groups than in the CON group ( P < .O 1). Under normal conditions, blood insulin concentrations tend to exhibit a positive correlation with blood glucose concentrations (Brockman and Laarveld, 1986) ; however, in the present study, insulin concentrations did not respond to elevated glucose concentrations during the Urea Load Test (Table 4 ). This response is characteristic of hyperammonemia and the Urea Load Test (Fernandez et al., 1990a,b) . The lower peak and subsequent concentrations of ammonia N, urea N, and glucose found in the goats receiving the MIM, 2,3-DHP, and MIM+2,3-DHP treatments may be indicative of an accelerated nitrogen metabolism in response to the Leucaena toxins. It has been reported that 3,4-DHP inhibits the enzyme catechol-0-methyltransferase (Hegarty et al., 1979) that participates in the inactivation or metabolism of the catecholamines epinephrine and norepinephrine (Phillis, 1976) resulting in hyperactivity. We can speculate that epinephrine and norepinephrine activity may have been enhanced by 2,3-DHP or MIM, which, in turn, would have profound effects on metabolism due to their critical role in the autonomic nervous system and adrenal medulla (Brockman and Laarveld, 1986) . Further research needs to be conducted on the effect of these Leucaena toxins on catecholamine secretion and function.
Implications
Short-term exposure to the purified toxins found in the promising leguminous shrub or tree, Leucaena leucocephala, did not affect goats' ability to respond to metabolic tests designed to assess their ability to produce glucose from propionate and detoxify ammonia. In fact, metabolism of a known deleterious foreign substance (in this case, ammonia) was actually improved by administration of mimosine and 2,3-dihydroxypyridine. The initial elevation of the thyroid hormone triiodothyronine in response to mimosine and 2,3-dihydroxypyridine administration may be indicative of the particular protocol used in this experiment and not necessarily that observed over longer periods of exposure to the toxins.
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